ERBB2 and neoplasm: These features included tumor aggressiveness markers (e.g., vascular and perineural invasion, histological subtype, tumor grade), molecular biomarkers (e.g., HER2, PD-L1, CK20, GATA3, Uroplakin III), and behavioral factors (e.g., smoking and alcohol consumption).